IMUNON Announces Up to $10 Million Cash Financing

Includes up-front issuance of preferred stock for $2.5 million and secured  promissory notes for $7.72 million

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.